Viatris Inc.
VTRS Healthcare Drug Manufacturers Specialty & Generic
Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.
Follow VTRS
Viatris Inc. (VTRS) Book value per share
Viatris Inc.'s book value per share at the end of fiscal 2025 was 12.6×, down 19.5% from 15.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 12.3×. Over the past ten years it has ranged from 12.6× (fiscal 2025) to 38.2× (fiscal 2020) — the current reading is the lowest in ten years. Viatris Inc. ranks 16th of 86 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 12.6× | (19.53%) |
| FY2024 | 15.6× | (8.42%) |
| FY2023 | 17.1× | (1.92%) |
| FY2022 | 17.4× | 2.55% |
| FY2021 | 17.0× | (55.60%) |
| FY2020 | 38.2× | 65.69% |
| FY2019 | 23.0× | (2.56%) |
| FY2018 | 23.6× | (5.02%) |
| FY2017 | 24.9× | 14.88% |
| FY2016 | 21.7× | 4.79% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 12.3× | (3.37%) |
| Mar 2026 | 12.7× | 0.96% |
| Dec 2025 | 12.6× | (3.83%) |
| Sep 2025 | 13.1× | (1.56%) |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UTHR United Therapeutics Corporation compare | 150× |
| NBIX Neurocrine Biosciences, Inc. compare | 36.6× |
| TAK Takeda Pharmaceutical Co. compare | 15.1× |
| ELAN Elanco Animal Health Incorporated compare | 13.2× |
| VTRS Viatris Inc. | 12.3× |
| ZTS Zoetis Inc. compare | 7.5× |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 6.7× |
| RDY Dr. Reddy's Laboratories Ltd compare | 5.2× |
| HLN Haleon PLC Sponsored ADR compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on VTRS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement